These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 32387213

  • 1. The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials.
    Wen Y, Li J, Long Q, Yue CC, He B, Tang XG.
    Int J Surg; 2020 Jul; 79():111-119. PubMed ID: 32387213
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials.
    Niu HL, Xiao JY.
    Int J Surg; 2020 Mar; 75():116-127. PubMed ID: 32014597
    [Abstract] [Full Text] [Related]

  • 3. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW, Clark WK, Moore DJ, Whorwell PJ.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD003960. PubMed ID: 17943807
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials.
    Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K.
    Am J Clin Nutr; 2014 Oct 17; 100(4):1075-84. PubMed ID: 25099542
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Meta-analysis of randomized controlled trials of the effects of probiotics on functional constipation in adults.
    Zhang C, Jiang J, Tian F, Zhao J, Zhang H, Zhai Q, Chen W.
    Clin Nutr; 2020 Oct 17; 39(10):2960-2969. PubMed ID: 32005532
    [Abstract] [Full Text] [Related]

  • 9. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
    Videlock EJ, Cheng V, Cremonini F.
    Clin Gastroenterol Hepatol; 2013 Sep 17; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Zheng Y, Yu T, Tang Y, Xiong W, Shen X, Jiang L, Lin L.
    PLoS One; 2017 Sep 17; 12(3):e0172846. PubMed ID: 28291778
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T, Mozaffari S, Nikfar S, Abdollahi M.
    World J Gastroenterol; 2015 Mar 14; 21(10):3072-84. PubMed ID: 25780308
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R, Nikfar S, Abdollahi M.
    Clin Ther; 2008 May 14; 30(5):884-901. PubMed ID: 18555935
    [Abstract] [Full Text] [Related]

  • 13. Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials.
    Qi Q, Zhang Y, Chen F, Zuo X, Li Y.
    BMC Gastroenterol; 2018 Jan 08; 18(1):5. PubMed ID: 29310568
    [Abstract] [Full Text] [Related]

  • 14. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW, Clark WK, Moore DJ, Whorwell PJ.
    Cochrane Database Syst Rev; 2004 Jan 08; (1):CD003960. PubMed ID: 14974049
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.
    Black CJ, Burr NE, Quigley EMM, Moayyedi P, Houghton LA, Ford AC.
    Gastroenterology; 2018 Dec 08; 155(6):1753-1763. PubMed ID: 30144426
    [Abstract] [Full Text] [Related]

  • 16. Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Wang M, Xie X, Zhao S, Ma X, Wang Z, Zhang Y.
    Front Immunol; 2023 Dec 08; 14():1136343. PubMed ID: 37275867
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cisapride for intestinal constipation.
    Aboumarzouk OM, Agarwal T, Antakia R, Shariff U, Nelson RL.
    Cochrane Database Syst Rev; 2011 Jan 19; (1):CD007780. PubMed ID: 21249695
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.
    Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM.
    Gut; 2010 Mar 19; 59(3):325-32. PubMed ID: 19091823
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
    Sun JR, Kong CF, Qu XK, Deng C, Lou YN, Jia LQ.
    Saudi J Gastroenterol; 2020 Mar 19; 26(2):66-77. PubMed ID: 31898645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.